Pitfalls in cefepime titration from human plasma: Plasma- and temperature-related drug degradation in vitro

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3654-3656

  Bugnon, Denis ^a   Giannoni, Eric ^a   Majcherczyk, Paul ^a   Glauser, Michel P ^a   Moreillon, Philippe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEPHALOSPORIN DERIVATIVE; PLASMA PROTEIN;

ARTICLE; BIOASSAY; BLOOD SAMPLING; DRUG DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PLASMA; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE;

CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; TEMPERATURE; ULTRAFILTRATION;

EID: 0036838786     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3654-3656.2002     Document Type: Article

References (15)

1. Barbhaia, R. H., S. T. Forgue, W. C. Shyu, E. A. Papp, and K. A. Pittman. 1987. High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine. Antimicrob. Agents Chemother. 31:55-59.
2. Barbhaiya, R. H., S. T. Forgue, C. R. Gleason, C. A. Knupp, K. A. Pittman, D. J. Weidler, and R. R. Martin. 1990. Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses. Antimicrob. Agents Chemother. 34:1118-1122.
3. Barbhaiya, R. H., C. A. Knupp, S. T. Forgue, G. R. Matzke, C. E. Halstenson, J. A. Opsahl, and K. A. Pittman. 1991. Disposition of the cephalosporin cefepime in normal and renally impaired subjects. Drug Metab. Dispos. 19:68-73.
4. Barbhaiya, R. H., S. T. Forgue, C. R. Gleason, C. A. Knupp, K. A. Pittman, D. J. Weidler, H. Movahhed, J. Tenney, and R. R. Martin. 1992. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. Antimicrob. Agents Chemother. 36:552-557.
5. Barbhaiya, R. H., C. A. Knupp, and K. A. Pittman. 1992. Effect of age and gender on pharmacokinetics of cefepime. Antimicrob. Agents Chemother. 36:1181-1185.
6. Breilh, D., C. Lavallée, A. Fratta, D. Ducint, P. Cony-Makhoul, and M. C. Saux. 1999. Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction. J. Chromatogr. B 734:121-127.
7. Elkhaïli, H., L. Linger, H. Montell, and F. Jehl. 1997. High-performance liquid chromatographic assay for cefepime in serum. J. Chromatogr. B Biomed. Sci. Appl. 690:181-188.
8. Forgue, S. T., P. Kari, and R. Barbhaiya. 1987. N-Oxidation of N-methylpyrrolidine released in vivo from cefepime. Drug Metab. Dispos. 15:808-815.
9. Fubara, J. O., and R. E. Notari. 1998. Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions. J. Pharm. Sci. 87:1572-1576.
10. Majcherczyk, P. A., P. Moreillon, L. A. Decosterd, D. Sanglard, J. Bille, M. P. Glauser, and O. Marchetti. 2002. Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. J. Pharm. Biomed. Anal. 28:645-651.
11. National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing: eleventh informational supplement, M100-S11, vol. 21, no. 1. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Rabouan-Guyon, S. M., A. F. Guet, P. Y. Courtois, and D. M. C. Barthes. 1997. Stability study of cefepime in different infusion solutions. Int. J. Pharm. 154:185-190.
13. Reed, M. D., T. S. Yamashita, C. A. Knupp, J. M. Veazey, Jr., and J. L. Blumer. 1997. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children. Antimicrob. Agents Chemother. 41:1783-1787.
14. Shah, V. P., K. K. Midha, S. Dighe, I. J. McGilveray, J. P. Skelly, A. Yacobi, T. Layloff, C. T. Viswanathan, C. E. Cook, R. D. McDowall, K. Pittman, and S. Spector. 1991. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report. Eur. J. Drug Metab. Pharmacokinet. 16:249-255.
15. Valassis, I. N., M. Parissi-Poulou, and P. Macheras. 1999. Quantitative determination of cefepime in plasma and vitreous fluid by chromatography. J. Chromatogr. B 721:249-255.